322 related articles for article (PubMed ID: 36442748)
1. Ferroptosis induction via targeting metabolic alterations in head and neck cancer.
Lee J; Roh JL
Crit Rev Oncol Hematol; 2023 Jan; 181():103887. PubMed ID: 36442748
[TBL] [Abstract][Full Text] [Related]
2. Lipid metabolism alterations and ferroptosis in cancer: Paving the way for solving cancer resistance.
Lee J; Shin D; Roh JL
Eur J Pharmacol; 2023 Feb; 941():175497. PubMed ID: 36621602
[TBL] [Abstract][Full Text] [Related]
3. Altered iron metabolism as a target for ferroptosis induction in head and neck cancer.
Lee J; Roh JL
Cell Oncol (Dordr); 2023 Aug; 46(4):801-810. PubMed ID: 36811720
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 targeting in overcoming ferroptosis evasion in head and neck cancer.
Roh JL
Biochem Biophys Res Commun; 2023 Sep; 671():225-228. PubMed ID: 37307705
[TBL] [Abstract][Full Text] [Related]
5. Induction of ferroptosis in head and neck cancer: A novel bridgehead for fighting cancer resilience.
Lee J; Roh JL
Cancer Lett; 2022 Oct; 546():215854. PubMed ID: 35973621
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
7. New Insights into Ferroptosis Initiating Therapies (FIT) by Targeting the Rewired Lipid Metabolism in Ovarian Cancer Peritoneal Metastases.
Zhan S; Yung MMH; Siu MKY; Jiao P; Ngan HYS; Chan DW; Chan KKL
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499591
[TBL] [Abstract][Full Text] [Related]
8. Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction.
Jehl A; Conrad O; Burgy M; Foppolo S; Vauchelles R; Ronzani C; Etienne-Selloum N; Chenard MP; Danic A; Dourlhes T; Thibault C; Schultz P; Dontenwill M; Martin S
Cells; 2023 Feb; 12(5):. PubMed ID: 36899869
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis.
Lee J; You JH; Shin D; Roh JL
Theranostics; 2020; 10(17):7775-7786. PubMed ID: 32685019
[No Abstract] [Full Text] [Related]
10. Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer.
Shin D; Lee J; You JH; Kim D; Roh JL
Redox Biol; 2020 Feb; 30():101418. PubMed ID: 31931284
[TBL] [Abstract][Full Text] [Related]
11. Promotion of ferroptosis in head and neck cancer with divalent metal transporter 1 inhibition or salinomycin.
Lee J; Roh JL
Hum Cell; 2023 May; 36(3):1090-1098. PubMed ID: 36890422
[TBL] [Abstract][Full Text] [Related]
12. The diversified role of mitochondria in ferroptosis in cancer.
Liu Y; Lu S; Wu LL; Yang L; Yang L; Wang J
Cell Death Dis; 2023 Aug; 14(8):519. PubMed ID: 37580393
[TBL] [Abstract][Full Text] [Related]
13. Iron, Ferroptosis, and Head and Neck Cancer.
Teng Y; Gao L; Mäkitie AA; Florek E; Czarnywojtek A; Saba NF; Ferlito A
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894808
[TBL] [Abstract][Full Text] [Related]
14. CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer.
Kim EH; Shin D; Lee J; Jung AR; Roh JL
Cancer Lett; 2018 Sep; 432():180-190. PubMed ID: 29928961
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal plasticity: Implications for ferroptosis vulnerability and cancer therapy.
Lee J; Roh JL
Crit Rev Oncol Hematol; 2023 May; 185():103964. PubMed ID: 36931615
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Ferroptosis and Application to Head and Neck Squamous Cell Carcinoma Treatments.
Li S; Liu Y; Li J; Zhao X; Yu D
DNA Cell Biol; 2021 Jun; 40(6):720-732. PubMed ID: 33979530
[TBL] [Abstract][Full Text] [Related]
17. Poly(rC)-binding protein 1 represses ferritinophagy-mediated ferroptosis in head and neck cancer.
Lee J; You JH; Roh JL
Redox Biol; 2022 May; 51():102276. PubMed ID: 35290903
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer.
Wang Y; Sun Y; Wang F; Wang H; Hu J
Biomed Pharmacother; 2023 Dec; 169():115866. PubMed ID: 37951026
[TBL] [Abstract][Full Text] [Related]
19. Iron metabolism, ferroptosis, and lncRNA in cancer: knowns and unknowns.
Qu L; He X; Tang Q; Fan X; Liu J; Lin A
J Zhejiang Univ Sci B; 2022 Oct; 23(10):844-862. PubMed ID: 36226538
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation.
Peleman C; Francque S; Berghe TV
EBioMedicine; 2024 Apr; 102():105088. PubMed ID: 38537604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
